Affinity label for β adrenergic receptor in turkey erythrocytes

D. Atlas, M. L. Steer, A. Levitzki

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Abstract

The compound N [2 hydroxy 3 (1 naphthoxy) propyl] N' bromoacetylethylenediamine (NHNP NBE) was found to label covalently the β adrenergic receptor in turkey erythrocytes. The compound inhibits irreversibly l epinephrine dependent adenylate cyclase activity [ATP pyrophosphate lyase (cyclizing), EC 4.6.1.1] in the whole turkey erythrocyte as well as in the erythrocyte membranes possessing the β receptor. The affinity label blocks, also irreversibly, the specific [3H]propranolol binding, whereas other bromoacetyl compounds tested have no effect on binding, even at high concentrations, which cause enzyme inactivation. l Epinephrine and propranolol offer protection against the affinity label in whole turkey erythrocytes as well as in membranes prepared from these cells. The potential usefulness of an irreversible β antagonist is discussed.

Original languageEnglish
Pages (from-to)1921-1925
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume73
Issue number6
DOIs
StatePublished - 1976

Fingerprint

Dive into the research topics of 'Affinity label for β adrenergic receptor in turkey erythrocytes'. Together they form a unique fingerprint.

Cite this